Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Events

Genomics Day 2005

 

Poster/Exhibit Session

View Agenda

Group 1: Genetics and Immunity
Immunogenetic factors in chronic beryllium disease

Weston A, Yucesoy B, Luster, M.
Health Effects Laboratory Division, NIOSH, CDC
Immunogenetic factors in chronic beryllium disease
View Abstract ]

no image available
Aslakson E, Vernon SD , Gurbaxani B, Miller A, Heim C, Reeves WC .
Division of Viral and Rickettsial Diseases, NCID, CDC
Modeling neuroendocrine regulation of the immune response

Vernon SD , Whistler T, Cameron B, Reeves WC, Floyd A.
Division of Viral and Rickettsial Diseases, NCID, CDC
The host gene expression response following acute Epstein Barr virus (EBV) infection

Udhayakumar V .
Division of Parasitic Diseases, NCID
Host genes and malaria

The impact of Fc receptor IIa for IgG (FcyIIa) polymorphism on malaria and HIV susceptibility in western Kenya

Brouwer KC1, Lal RB1, Mirel LB1, Yang C1, Van Eijk A2, Ayisi J2, Otieno J3, Nahlen BL4, Steketee R1, Lal A1, and Shi YP1.
(1) NCID, CDC
(2) Center for Vector Biology and Control Research, Kenya Medical Research Institute, Kisumu, Kenya
(3) New Nyanza Provincial General Hospital, Ministry of Health, Kisumu, Kenya,
(4) Roll Back Malaria Program, World Health Organization, Geneva, Switzerland

The impact of Fc receptor IIa for IgG (FcyIIa) polymorphism on malaria and HIV susceptibility in western Kenya
View Abstract ]

no image available
Nguyen L1, Li M1, Chaowanachan T2, Hu DJ1, Vanichseni S3, Mock PA2, Van Griensvena F2,
Martin M 1,2, Sangkum U4, Choopanya C3, Tappero JW1,2, Lal RB1, and Yang C1.
(1) CDC
(2) Thai MOPH-U.S. CDC Collaboration
(3) Bangkok Vaccine Evaluation Group, Thailand
(4) Bangkok Metropolitan Administration, Thailand

Association of CCR5 promoter human haplogroup E with faster HIV-1 disease progression among injection drug users (IDU) in Thailand
View Abstract ]

 

Group 2: Biomarker Discovery
Biomarker discovery for early detection of cervical neoplasia: gene expression profiling in exfoliated cervical cells

Steinau M1 , Lee DR1 , Rajeevan MS1 , Vernon SD1 , Ruffin MT2 ,Verma M2 , Srivastava S3, Unger ER1(1) Division of Viral and Rickettsial Diseases, NCID , DC ,
(2) University of Michigan,
(3) National Cancer Institute

Biomarker discovery for early detection of cervical neoplasia: gene expression profiling in exfoliated cervical cells
View Abstract ]

no image available

Rollin DD, Whistler T, Lee DR , Vernon SD , Gurbaxani B, Unger ER.
Division of Viral and Rickettsial Diseases, NCID, CDC
Protein profiling in cervical mucous samples for biomarker discovery
View Abstract ]

Reeves WC, Vernon SD , Whistler T, Unger ER, Nisenbaum R .
Division of Viral and Rickettsial Diseases, NCID, CDC
Population-based epidemiology integrated with genomics for identification of disease biomarkers

Exercise induced exacerbation of symptoms associated with chronic fatigue syndrome to identify differentially expressed fatigue genes

Whistler T, Vernon SD , Clancy K, Jones JF, Reeves WC.
Division of Viral and Rickettsial Diseases, NCID, CDC
Exercise induced exacerbation of symptoms associated with chronic fatigue syndrome to identify differentially expressed fatigue genes
View Abstract ]

 

Group 3: Bioinformatics
no image available

Rajeevan M, Dimulescu I, Nicholson A, Vernon SD , Unger ER.
Division of Viral and Rickettsial Diseases, NCID, CDC
Global amplification of sense RNA: a novel method to archive and replicate RNA for microarrays

Craddock RC, Aslakson E, Vernon SD.
Division of Viral and Rickettsial Diseases, NCID, CDC
Development of a gene expression microarray database for flexible data processing, analysis and archiving

Tiller M, Aslakson E, Vernon SD.
Division of Viral and Rickettsial Diseases, NCID, CDC
Development of a text mining tool that provides gene information in specific disease and biological context

Savel T1, Lin B2, CDC/NCI NHANES Working Group on Genomics .
(1) NCBDDD and (2) OGDP, CDC
The future of transmitting human genomic data in the Public Health Information Network (PHIN): using a prototype Health Level 7 shared genotype refined message information model (HL7 R-MIM) and the extensible markup language (XML)

* Wei Yu1,2, Bruce Lin3, Mary Lou Lindegren3, Dale Nordenberg1 and Muin J. Khoury3
(1) Office of Informatics, NCID, CDC, Atlanta, GA, USA
(2) Public Health Informatics Fellowship Program, OWCD, CDC, Atlanta, GA, USA
(3) Office of Genomics and Disease Prevention, CDC, Atlanta, GA, USA

GeneSelectAssist: A Bioinformatics Tool for Candidate Gene Selection and Prioritization for Clinical and Public Health Research

 

Group 4: Public Health Research and Practice
Project HeartBeat!

Dai S, Labarthe DR , Fulton JE, Grunbaum J.
NCCDPHP, CDC
Apolipoprotein E affects serial changes in total and low-density lipoprotein cholesterol in adolescent girls: Project HeartBeat!
View Abstract ]

The National Birth Defects Prevention Study Centralized Laboratory

Gallagher M1, Sturchio C1, Honein M2.
(1) NCEH
(2) NCBDDD, CDC

The National Birth Defects Prevention Study Centralized Laboratory
View Abstract ]

Casey C, Vellozzi C, Gee J, Destefano F.
NIP, CDC
Incorporating genomics into the National Immunization Program's extramural vaccine safety research: highlights of three Immunization Safety Branch studies

no image available

Lindegren ML, Moore C, Lyn S and the CDC/CSTE APHI Working Group
OGDP, CDC
The role of human genomics in acute public health investigations: current practices and future strategies

Tessaro I1, Coughlin S2, Wu Y1.
(1) West Virginia University
(2) Division of Cancer Prevention and Control, NCCDPHP, CDC

Colorectal cancer screening and prevention practices among Appalachian men and women with a positive family history

Designing a study to examine family history, risk perception, cancer worry and use of ovarian cancer screening

Peipins LA, Hawkins N, Coughlin S, Dawkins N.
Division of Cancer Prevention and Control, NCCDPHP, CDC
Designing a study to examine family history, risk perception, cancer worry and use of ovarian cancer screening
View Abstract ]

Reyes M, Dunet D, Ward G.
Division of Nutrition and Physical Activity, NCCDPHP, CDC
Family-based detection for hereditary hemochromatosis

no image available

McCanlies EC, Schuler C, Kreiss K, Weston A .
Health Effects Laboratory Division, NIOSH, CDC
Educating beryllium workers about genetic information
View Abstract ]

Newborn screening for cystic fibrosis: benefits, risks and recommendations

Grosse SD, Boyle CA , Green DR.
NCBDDD, CDC
Newborn screening for cystic fibrosis: benefits, risks and recommendations
View Abstract ]

Ford C1 Meredith NC2.
(1) National Center for Health Marketing
(2) NCEH, CDC

A new era in newborn screening--saving lives, improving outcomes

 

Group 5: Communicating Genetic Information

Lubin IM1, Prue C2, Flores A3, Reed K3.
(1) National Center for Health Marketing
(2) NCBDDD
(3) Association of Schools of public Health

The news media as an avenue for informing the public about genetic testing: what messages are being communicated?

Constantin C1,2 and Lubin IM1.
(1) National Center for Health Marketing, CDC
(2) Oak Ridge Institute for Science and Education, Oak Ridge , TN

Promoting effective communication in the use of genetic tests

no image available

Whitehead NS1, Rasmussen S2, Posner S1, Cox S11.
(1) NCCDPHP
(2) NCBDDD, CDC

The prevalence of prenatal discussion of genetic screening
View Abstract ]

Medical school use of “Genetics in Clinical Practice: A Team Approach

Faucett WA1 , Smith H2 , Henderson JV3.
(1) Oak Ridge Institute for Science and Education, CDC, Emory University School of Medicine
(2) University of Arkansas Medical School Library
(3) Dartmouth Medical School, Interactive Media Laboratory

Medical school use of “Genetics in Clinical Practice: A Team Approach”
View Abstract ]

 

Group 6: Quality Assurance
Promoting quality laboratory testing for rare diseases

Chen B1, Faucett WA1, Boone DJ1, Groft SC2, Spinella G2, Ledbetter DH3, Boughman J4, Greene C5, Lloyd-Puryear M6, Terry S7, and Watson M8.
(1)Division of Laboratory Services, National Center for Health Marketing, CDC,
(2)Office of Rare Diseases, NIH,
(3)Emory University School of Medicine,
(4)American Society of Human Genetics,
(5)Department of Health and Human Services,
(6)Health Resources and Services Administration,
(7)Genetic Alliance, and
(8)American College of Medical Genetics

Promoting quality laboratory testing for rare diseases: key to ensuring quality genetic testing
[ View Abstract ]

materials for genetic testing

Kalman L, Chen B, Lubin IM, Boone J.
Division of Laboratory Services, National Center for Health Marketing, CDC
A sustainable community process to improve availability of appropriate, verified quality control (QC) materials for genetic testing
View Abstract ]

Bell C for the Newborn Screening Branch.
Division of Laboratory Sciences, NCEH, CDC
Activities of the newborn screening quality assurance program

 

 

Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd.
    Atlanta, GA 30333 USA
    800-CDC-INFO (800-232-4636)
  • Additional information for Public Health Genomics is available on our contact page.
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #